2m 2m 2m 2m 2m 2m 2m
TEVAPHARMIND SP ADR (TEVA)
NYSE
$33.09+$0.88 (+2.75%)
Price as of Jun 23, 2026 7:48 PM EDT- $37.5BMarket Cap
- 89.75%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
TEVAPHARMIND SP ADR (TEVA)
$33.09+$0.88 (+2.75%)
TEVA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $32.20 | ||
Change | +$0.72 (+2.29%) | ||
Open | $31.37 | ||
High | $32.39 | ||
Low | $31.28 | ||
Previous Close | $31.48 | ||
Volume | 6,111,093 | ||
30-Day Average Volume | 6,631,104 | ||
1-Week Change | -4.42% | ||
1-Month Change | -5.49% | ||
1-Year Change | 89.75% | ||
3-Year Change | 326.49% | ||
5-Year Change | 217.24% | ||
Fundamentals | |||
Shares Outstanding | 1.2B | ||
Total Assets | $40.0B | ||
Market Cap | $37.5B | ||
Enterprise Value | $50.4B | ||
Period: QTR TTM FY | |||
Revenue | $4.0B | ||
Net Income | $369.0M | ||
Free Cash Flow | -$208.0M | ||
EBIT | $436.0M | ||
EBITDA | $675.0M | ||
Net Working Capital | $178.0M | ||
EPS | $0.31 | ||
Enterprise Value/EBITDA | 75 | ||
Enterprise Value/Revenue | 13 | ||
P/B | 5 | ||
P/E | 104 | ||
PEG | -4 | ||
Price/Free Cash Flow | -180 | ||
Price/Operating Cash Flow | -937 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 11/27/2017 | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 12/06/2002 | ||
Earnings & Revenue